Cannabis Global Inc CBGL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $209,031.05
- Volume/Avg
- 15.7 Mil / 45.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cannabis Global manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 3
Valuation
|
Metric
|
CBGL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CBGL
Financial Strength
|
Metric
|
CBGL
|
|---|---|
Quick Ratio | 0.11 |
Current Ratio | 0.21 |
Interest Coverage | 0.27 |
Quick Ratio
CBGL
Profitability
|
Metric
|
CBGL
|
|---|---|
Return on Assets (Normalized) | −48.76% |
Return on Equity (Normalized) | −674.40% |
Return on Invested Capital (Normalized) | −13.37% |
Return on Assets
CBGL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rxzjxypnbp | Ldxq | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Wgrvktmyq | Yfmwjdt | $68.1 Bil | |
HLN
| Haleon PLC ADR | Cqlnxbxq | Jpl | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Rvxlcpjtk | Xjvt | $14.3 Bil | |
VTRS
| Viatris Inc | Vwmvggksk | Nwwln | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Rbdylycbc | Dfg | $11.9 Bil | |
CTLT
| Catalent Inc | Kcxnxgchj | Rfyctds | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Wktbzlghh | Rnjlg | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Bdrgtlnq | Vlfx | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dyglrbycx | Rztctk | $3.4 Bil |